ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

ORI Final Findings Of Scientific Misconduct

September 16, 1994

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999